Presence of donor- and recipient-derived DNA in cell-free urine samples of renal transplantation recipients: Urinary DNA chimerism

Clinical Chemistry

Volumn 45, Issue 10, 1999, Pages 1741-1746

  Zhang, Jun ^a   Tong, Kwok Lung ^b   Li, Philip K T ^a   Chan, Albert Y W ^b   Yeung, Chung Kwong ^a   Pang, Calvin C P ^a   Wong, Teresa Y H ^a   Lee, Kam Cheong ^b   Lo, Y M Dennis ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b PRINCESS MARGARET HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBIN; DNA;

ARTICLE; CHIMERA; CLINICAL ARTICLE; FEMALE; GRAFT REJECTION; HUMAN; KIDNEY TRANSPLANTATION; MALE; MICROCHIMERISM; ORGAN DONOR; PATIENT MONITORING; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; URINALYSIS;

EID: 0032855152     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/45.10.1741     Document Type: Article

References (29)

1. 1. Starzl TE, Demetris AJ, Murase N, Ildstad S, Ricordi C, Trucco M. Cell migration, chimerism, and graft acceptance [Review]. Lancet 1992;339:1579-82.
2. 2. Starzl TE, Demetris AJ, Trucco M, Ramos H, Zeevi A, Rudert WA, et al. Systemic chimerism in human female recipients of male livers. Lancet 1992;340:876-7.
3. 3. Starzl TE, Demetris AJ, Trucco M, Ricordi C, Ildstad S, Terasaki PI, et al. Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med 1993;328:745-9.
4. 4. Starzl TE, Demetris AJ, Trucco M, Zeevi A, Ramos H, Terasaki P, et al. Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation 1993;55:1272-7.
5. 5. Starzl TE, Demetris AJ, Trucco M, Murase N, Ricordi C, Ildstad S, et al. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology 1993;17:1127-52.
6. 6. Starzl TE, Demetris AJ, Murase N, Thomson AW, Trucco M, Ricordi C. Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol Today 1993;14:326-32.
7. 7. Schlitt HJ, Hundrieser J, Hisanaga M, Uthoff K, Karck M, Wahlers T, et al. Patterns of donor-type microchimerism after heart transplantation. Lancet 1994;343:1469-71.
8. 8. Suberbielle C, Caillat-Zucman S, Legendre C, Bodemer C, Noel LH, Kreis H, et al. Peripheral microchimerism in long-term cadaveric-kidney allograft recipients. Lancet 1994;343:1468-9.
9. 9. Schlitt HJ, Hundrieser J, Ringe B, Pichlmayr R. Donor-type microchimerism associated with graft rejection eight years after liver transplantation [Letter]. N Engl J Med 1994;330:646-7.
10. 10. Chen Y, Baltzan M, George D, Bohm C, Okasha K, Shoker A. Fate of recurrent acute interstitial cellular rejection in an HLA identical kidney transplant recipient: impact of donor microchimerism. Clin Nephrol 1997;48:300-6.
11. 11. Elwood ET, Larsen CP, Maurer DH, Routenberg KL, Neylan JF, Whelchel JD, et al. Microchimerism and rejection in clinical transplantation. Lancet 1997;349:1358-60.
12. 12. Adams DH, Hutchinson IV. Microchimerism and graft tolerance: cause or effect? [Editorial]. Lancet 1997;349:1336-7.
13. 13. Wood K, Sachs DH. Chimerism and transplantation tolerance: cause and effect. Immunol Today 1996;17:584-7.
14. 14. Sahota A, Yang M, McDaniel HB, Sidner RA, Book B, Barr R, et al. Evaluation of seven PCR-based assays for the analysis of microchimerism. Clin Biochem 1998;31:641-5.
15. 15. McDaniel HB, Yang M, Sidner RA, Jindal RM, Sahota A. Prospective study of microchimerism in transplant recipients. Clin Transplant 1999;13:187-92.
16. 16. Lo YMD, Tein MSC, Pang CCP, Yeung CK, Tong KL, Hjelm NM. Presence of donor-specific DNA in plasma of kidney and liver-transplant recipients [Letter]. Lancet 1998;351:1329-30.
17. 17. Yokota M, Tatsumi N, Tsuda I, Takubo T, Hiyoshi M. DNA extraction from human urinary sediment. J Clin Lab Anal 1998;12:88-91.
18. 18. Steiner G, Schoenberg MP, Linn JF, Mao L, Sidransky D. Detection of bladder cancer recurrence by microsatellite analysis of urine. Nat Med 1997;3:621-4.
19. 19. Fitzgerald JM, Ramchurren N, Rieger K, Levesque P, Silverman M, Libertino JA, et al. Identification of H-ras mutations in urine sediments complements cytology in the detection of bladder tumors. J Natl Cancer Inst 1995;87:129-33.
20. 20. Saito S, Hata M, Fukuyama R, Sakai K, Kudoh J, Tazaki H, et al. Screening of H-ras gene point mutations in 50 cases of bladder carcinoma. Int J Urol 1997;4:178-85.
21. 21. Lo YMD, Tein MSC, Lau TK, Haines CJ, Leung TN, Poon PMK, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998;62:768-75.
22. 22. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res 1996;6:986-94.
23. 23. Longo MC, Berninger MS, Hartley JL. Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions. Gene 1990;93:125-8.
24. 24. Sharma VK, Ding R, Li B, Bologa RM, Lagman M, Eduafo A, et al. Molecular correlates of human renal allograft rejection. Transplant Proc 1998;30:2364-6.
25. 25. Matsuno T, Nakagawa K, Sasaki H, Ishine N, Inagaki M, Yagi T, et al. Apoptosis in acute tubular necrosis and acute renal allograft rejection. Transplant Proc 1994;26:2170-3.
26. 26. Matsuno T, Sasaki H, Ishido N, Nakagawa K, Ishikawa T, Oishi A, et al. Apoptosis in human kidney allografts. Transplant Proc 1996;28:1226-7.
27. 27. Rogers JC, Boldt D, Kornfeld S, Skinner A, Valeri CR. Excretion of deoxyribonucleic acid by lymphocytes stimulated with phytohemagglutinin or antigen. Proc Natl Acad Sci U S A 1972;69:1685-9.
28. 28. Distelhorst CW, Rogers JC. Glucocorticoids inhibit trypsin-induced DNA release from phytohemagglutinin-stimulated blood lymphocytes. J Immunol 1979;123:487-95.
29. 29. Barnas U, Mayer G. Glomerular proteinuria in renal transplant patients: mechanisms and treatment. Kidney Int 1997;52(Suppl 63):S78-80.